Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Hematologic Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00008177
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+14 more
Fred Hutchinson Cancer Center 79
Large-scale testing (Phase 3)Study completedNCT00322101
What this trial is testing

Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Myeloid Leukemia/Transient Myeloproliferative DisorderAdult Acute Myeloid Leukemia in Remission+16 more
Fred Hutchinson Cancer Center 25
Not applicableLooking for participantsNCT07616921
What this trial is testing

A Home-Based Exercise Intervention (CAREFit-BMT) in Improving Heart Function Among Patients With High Risk Acute Myeloid Leukemia Undergoing Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia
University of Washington 30
Testing effectiveness (Phase 2)Study completedNCT01289457
What this trial is testing

Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 282
Testing effectiveness (Phase 2)Active Not RecruitingNCT00869232
What this trial is testing

UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

Who this might be right for
Multiple Myeloma
University of Arkansas 90
Testing effectiveness (Phase 2)Ended earlyNCT01303965
What this trial is testing

Allo Transplant Followed by Lenalidomide and Sirolimus Maintenance in High-Risk Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Sherif S. Farag 14
Early research (Phase 1)WithdrawnNCT00458744
What this trial is testing

Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaLymphoma+1 more
Children's Oncology Group
Testing effectiveness (Phase 2)WithdrawnNCT00003407
What this trial is testing

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaMyelodysplastic Syndromes+1 more
Rush University Medical Center
Large-scale testing (Phase 3)Looking for participantsNCT06093672
What this trial is testing

Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

Who this might be right for
Polycythemia Vera
Italfarmaco 220
Large-scale testing (Phase 3)Ended earlyNCT00038805
What this trial is testing

Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT02308280
What this trial is testing

Nonmyeloablative Allogeneic Stem Cell Transplant Followed by Bortezomib in High-risk Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaHigh-Risk Cancer
Maisonneuve-Rosemont Hospital 40
Testing effectiveness (Phase 2)Study completedNCT01249820
What this trial is testing

Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal Disease

Who this might be right for
LeukemiaMyelodysplastic SyndromeLeukemia, Myeloid, Acute
Radboud University Medical Center 26
Large-scale testing (Phase 3)UnknownNCT00651261
What this trial is testing

Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Leukemia
Alliance for Clinical Trials in Oncology 717
Testing effectiveness (Phase 2)UnknownNCT03080922
What this trial is testing

High Dose Donor Hematopoietic Stem Cell Infusion for Relapsed/Refractory AML

Who this might be right for
Leukemia, Myeloid
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 10
Early research (Phase 1)Looking for participantsNCT04375631
What this trial is testing

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Who this might be right for
Recurrent Acute Myeloid LeukemiaRecurrent Chronic Myelomonocytic LeukemiaRecurrent Myelodysplastic Syndrome+6 more
Fred Hutchinson Cancer Center 120
Testing effectiveness (Phase 2)Study completedNCT01484275
What this trial is testing

Siltuximab (Anti- IL 6 Monoclonal Antibody) in Patients With High-risk Smoldering Multiple Myeloma

Who this might be right for
High-risk Smoldering Multiple Myeloma
Janssen Research & Development, LLC 85
Testing effectiveness (Phase 2)Study completedNCT00516828
What this trial is testing

Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
NCIC Clinical Trials Group 21
Testing effectiveness (Phase 2)WithdrawnNCT03003728
What this trial is testing

2015-10: Expanded Natural Killer Cells and Elotuzumab for High-Risk Myeloma Post- Autologous Stem Cell Transplant (ASCT)

Who this might be right for
Multiple Myeloma
University of Arkansas
Large-scale testing (Phase 3)Active Not RecruitingNCT01169337
What this trial is testing

Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma

Who this might be right for
Light Chain Deposition DiseaseSmoldering Multiple Myeloma
National Cancer Institute (NCI) 226
Testing effectiveness (Phase 2)Study completedNCT00002865
What this trial is testing

High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia

Who this might be right for
Leukemia
Wake Forest University Health Sciences 25
Next Page